Company Culture

Discussion in 'Alimera Sciences' started by anonymous, Mar 18, 2017 at 1:52 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    What’s the line on how much money is left?

    $4, $6, $8 million?
     

  2. anonymous

    anonymous Guest

    [​IMG]
     
  3. anonymous

    anonymous Guest

    Lenweaver v. Alimera Sciences, Inc.

    STIPULATION WITH PROPOSED ORDER TO CONTINUE COURT ORDERED MEDIATION DATE AND STATUS CONFERENCE filed by Alimera Sciences, Inc., Laura Cegala, Cherie Hyder. (Weintraub, Brad)
     
  4. anonymous

    anonymous Guest

     
  5. anonymous

    anonymous Guest

    who gives a rats ass.
    She was a dingbat who’s demands were utterly rediculous. Has all the earmarks of a wishful....”hey let’s gets some cash quickly” scam.
     
  6. anonymous

    anonymous Guest

    Hope she wins
     
  7. anonymous

    anonymous Guest

    there are no winners dumb ass....it’s a settlement unless they prove it’s all bullshit.
     
  8. anonymous

    anonymous Guest

    you mad bro?
     
  9. anonymous

    anonymous Guest

    Why do these people have other last names? That wasn’t her name when she was here. Cherie has another last name Something to hide?
     
  10. anonymous

    anonymous Guest

    Dah.....got married?
     
  11. anonymous

    anonymous Guest

    is there enough money to pay bonuses?
     
  12. anonymous

    anonymous Guest

    just look up Cherie. She has a lot of former surnames
     
  13. anonymous

    anonymous Guest

    ALIM

    Profitability
    Profit Margin -61.02%
    Operating Margin (ttm) -43.16%
    Management Effectiveness
    Return on Assets (ttm) -17.72%
    Return on Equity (ttm) -177.63%
     
  14. anonymous

    anonymous Guest

    This company is just sad
     
  15. anonymous

    anonymous Guest

    Cherie is not qualified, especially ethically, to lead anything, let alone a medical department. She kisses the butt of RE who is a huge failure...just look at the stock. It's a pathetic company and I cannot wait til all of us can get out. Novartis or elsewhere!
     
  16. anonymous

    anonymous Guest

    Conference Date: Tuesday, November 6, 2018, 9:00 AM ET
    Conference Dial-In: 877.269.7756
    International Dial-In: 201.689.7817
    Conference Call Name: Alimera Sciences (ALIM) Third Quarter 2018 Results Call
     
  17. anonymous

    anonymous Guest

    Net loss for the three months ended September 30, 2018 was approximately $3.5 million
     
  18. anonymous

    anonymous Guest

    As of September 30, 2018, Alimera had cash and cash equivalents of approximately $12.6 million.
     
  19. anonymous

    anonymous Guest

    These guys are a hoot....when a distributor buys in its”record sales”. When a distributor does not buy in, it’s soft sales due to previous quarter or same quarter last year had a distributor order. The song they play is getting old. Also when you increase sales by 1M what you are really talking about globally is 100 total units, which is quite minuscule relative speaking.